Medicine & Life Sciences
Natalizumab
100%
Crohn Disease
66%
Cell Migration Inhibition
16%
Integrin alpha Chains
16%
Progressive Multifocal Leukoencephalopathy
15%
Remission Induction
15%
Biological Therapy
13%
Biological Factors
12%
Therapeutics
11%
Endothelium
10%
Immunosuppressive Agents
9%
Tumor Necrosis Factor-alpha
8%
Safety
6%
Antibodies
6%
Chemical Compounds
Refractory
72%
Tumor Necrosis Factor Inhibitor
71%
Biologic Agent
48%
Immunosuppressive Agent
46%
Safety
29%
Engineering & Materials Science
Tumor Necrosis Factor-alpha
43%
Refractory materials
25%
Antibodies
14%
Molecules
11%
Cells
11%
Adhesion
10%
Social Sciences
management
33%
evidence
29%
induction
11%
indication
10%
migration
8%
history
6%